BIOMARIN PHARMACEUTICAL INC Quarterly Debt-to-equity in % from Q1 2011 to Q3 2024

Taxonomy & unit
ratio: %
Description
Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary
Biomarin Pharmaceutical Inc quarterly Debt-to-equity history and growth rate from Q1 2011 to Q3 2024.
  • Biomarin Pharmaceutical Inc Debt-to-equity for the quarter ending September 30, 2024 was 33.3 %, a 12.2% decline year-over-year.
Debt-to-equity, Quarterly (%)
Debt-to-equity, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date
Q3 2024 33.3 -4.62 -12.2% Sep 30, 2024
Q2 2024 36.3 -1.45 -3.84% Jun 30, 2024
Q1 2024 37.2 -0.35 -0.93% Mar 31, 2024
Q4 2023 37.9 +0.33 +0.88% Dec 31, 2023
Q3 2023 38 -0.13 -0.34% Sep 30, 2023
Q2 2023 37.7 -1.11 -2.86% Jun 30, 2023
Q1 2023 37.6 -1.98 -5.01% Mar 31, 2023
Q4 2022 37.6 -2.34 -5.87% Dec 31, 2022
Q3 2022 38.1 -2.22 -5.51% Sep 30, 2022
Q2 2022 38.8 -4.33 -10% Jun 30, 2022
Q1 2022 39.5 -9.04 -18.6% Mar 31, 2022
Q4 2021 39.9 -10.7 -21.1% Dec 31, 2021
Q3 2021 40.3 -12.6 -23.8% Sep 30, 2021
Q2 2021 43.2 -8.9 -17.1% Jun 30, 2021
Q1 2021 48.6 +0.44 +0.91% Mar 31, 2021
Q4 2020 50.5 +1.07 +2.16% Dec 31, 2020
Q3 2020 52.9 +3.69 +7.5% Sep 30, 2020
Q2 2020 52.1 -0.31 -0.59% Jun 30, 2020
Q1 2020 48.1 -7.22 -13% Mar 31, 2020
Q4 2019 49.5 -9 -15.4% Dec 31, 2019
Q3 2019 49.2 -13.3 -21.3% Sep 30, 2019
Q2 2019 52.4 -10.6 -16.8% Jun 30, 2019
Q1 2019 55.3 -3.5 -5.95% Mar 31, 2019
Q4 2018 58.5 +4.96 +9.27% Dec 31, 2018
Q3 2018 62.5 +13.9 +28.5% Sep 30, 2018
Q2 2018 62.9 +18.8 +42.5% Jun 30, 2018
Q1 2018 58.8 +11.4 +24% Mar 31, 2018
Q4 2017 53.5 +1.53 +2.94% Dec 31, 2017
Q3 2017 48.6 -6.18 -11.3% Sep 30, 2017
Q2 2017 44.2 -14.3 -24.5% Jun 30, 2017
Q1 2017 47.5 -9.59 -16.8% Mar 31, 2017
Q4 2016 52 -2.75 -5.03% Dec 31, 2016
Q3 2016 54.8 -1.05 -1.88% Sep 30, 2016
Q2 2016 58.5 +2.17 +3.85% Jun 30, 2016
Q1 2016 57.1 -0.67 -1.16% Mar 31, 2016
Q4 2015 54.7 -6.43 -10.5% Dec 31, 2015
Q3 2015 55.9 -6.51 -10.4% Sep 30, 2015
Q2 2015 56.3 +1.97 +3.62% Jun 30, 2015
Q1 2015 57.7 +11.4 +24.6% Mar 31, 2015
Q4 2014 61.2 +23.3 +61.7% Dec 31, 2014
Q3 2014 62.4 +29.3 +88.5% Sep 30, 2014
Q2 2014 54.4 +14.8 +37.4% Jun 30, 2014
Q1 2014 46.3 -0.05 -0.11% Mar 31, 2014
Q4 2013 37.8 -19 -33.5% Dec 31, 2013
Q3 2013 33.1 -27.1 -45% Sep 30, 2013
Q2 2013 39.6 -24 -37.8% Jun 30, 2013
Q1 2013 46.4 -23.3 -33.5% Mar 31, 2013
Q4 2012 56.8 -14.6 -20.5% Dec 31, 2012
Q3 2012 60.2 -13.1 -17.9% Sep 30, 2012
Q2 2012 63.6 -19.7 -23.7% Jun 30, 2012
Q1 2012 69.7 -29.6 -29.8% Mar 31, 2012
Q4 2011 71.5 Dec 31, 2011
Q3 2011 73.3 Sep 30, 2011
Q2 2011 83.3 Jun 30, 2011
Q1 2011 99.3 Mar 31, 2011
* An asterisk sign (*) next to the value indicates that the value is likely invalid.